Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD) (ATTUNE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04951076
Recruitment Status : Recruiting
First Posted : July 6, 2021
Last Update Posted : March 3, 2022
Information provided by (Responsible Party):
Bionomics Limited

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2023
Estimated Study Completion Date : May 2023